As insurance companies start charging members for hospital-related costs again, analysis of 2020 data shows what they might owe.
Only 1 in 10 people with diabetes in low- and middle-income countries are getting evidence-based, low-cost comprehensive care.
Although the drug is commonly used to treat hepatorenal syndrome in other parts of the world, it lacks FDA approval. Researchers examine both its efficacy and safety.
From variants and vaccines to what lies ahead, CNN medical correspondent and University of Michigan alum shares insights.
Data from Michigan’s Medicaid expansion program could inform other states and programs.